08045800513
cmd@solitairegroup.in
Atorvastain calcium 10 mg & Fenofibrate 160 mg
Atorvastain calcium 10 mg & Fenofibrate 160 mg
Atorvastain calcium 10 mg & Fenofibrate 160 mg
Atorvastain calcium 10 mg & Fenofibrate 160 mg
Atorvastain calcium 10 mg & Fenofibrate 160 mg
Atorvastain calcium 10 mg & Fenofibrate 160 mg

Atorvastain calcium 10 mg & Fenofibrate 160 mg

MOQ : 15-30 Boxes

Atorvastain calcium 10 mg & Fenofibrate 160 mg Specification

  • Drug Type
  • Specific Drug
  • Ingredients
  • Telmisartan 40 mg & 80 mg
  • Physical Form
  • Tablets
  • Function
  • Other
  • Recommended For
  • Elevated total cholesterol
  • Suitable For
  • Adults, Aged Person
 

Atorvastain calcium 10 mg & Fenofibrate 160 mg Trade Information

  • Minimum Order Quantity
  • 15-30 Boxes
  • Sample Policy
  • Sample costs shipping and taxes has to be paid by the buyer
  • Packaging Details
  • Alu-ALu, 10*10 tablet, Packing
  • Main Domestic Market
  • All India
  • Certifications
  • WHO-GMP
 

About Atorvastain calcium 10 mg & Fenofibrate 160 mg



Atorvastatin Calcium 10 mg & Fenofibrate 160 mg tablets are specially formulated to support adults and aged individuals in managing elevated total cholesterol levels. Combining Atorvastatin, a cholesterol-lowering drug, and Fenofibrate, a lipid-altering agent, these tablets effectively reduce LDL cholesterol and triglycerides while promoting HDL cholesterol levels. Designed in tablet form for easy consumption, this specific drug is recommended for managing dyslipidemia and hypercholesterolemia. Ideal for those seeking a reliable pharmaceutical solution to maintain cardiovascular health, these tablets are manufactured to meet stringent quality standards. With comprehensive lipid-regulating properties, this product is trusted by healthcare providers for improving overall lipid profiles in adults.

FAQs of Atorvastain calcium 10 mg & Fenofibrate 160 mg:


Q: What is the purpose of Atorvastatin Calcium 10 mg & Fenofibrate 160 mg tablets?

A: These tablets are used to manage elevated total cholesterol and improve lipid profiles by reducing LDL cholesterol and triglycerides and increasing HDL cholesterol levels.

Q: Who is this product suitable for?

A: This product is ideal for adults and aged individuals who need to regulate their cholesterol levels.

Q: What is the physical form of this product?

A: The product is available in tablet form for convenient consumption.

Q: Is this drug recommended for specific conditions?

A: Yes, it is recommended for dyslipidemia, hypercholesterolemia, and cardiovascular health improvement.

Q: What are the key ingredients in this product?

A: The tablets contain a combination of Atorvastatin Calcium 10 mg and Fenofibrate 160 mg.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Cardiac Tablets Category

Prasugrel 10 mg (as Hydrochloride)

Prasugrel 10 mg (as Hydrochloride)

Minimum Order Quantity : 1530 Boxes

Drug Type : General Medicines

Ingredients : Telmisartan 40 mg & 80 mg

Function : Other

Physical Form : Tablets

Recommended For : Acute Coronary Syndrome

Atorvastatin 10 mg & Ezitamibe 10 mg

Atorvastatin 10 mg & Ezitamibe 10 mg

Minimum Order Quantity : 1530 Boxes

Drug Type : Specific Drug

Ingredients : Telmisartan 40 mg & 80 mg

Function : Other

Physical Form : Tablets

Recommended For : Reduces elevated total cholesterol, LDL and Apo B in patients with primary Hypercholesterolemia

Losartan Potassium 50 mg & Atenolol 50 mg

Losartan Potassium 50 mg & Atenolol 50 mg

Minimum Order Quantity : 1530 Boxes

Drug Type : Specific Drug

Ingredients : Telmisartan 40 mg & 80 mg

Function : Other

Physical Form : Tablets

Recommended For : Mild to moderate Hypertension

Rosuvastatin 5 mg/10 mg/20 mg

Rosuvastatin 5 mg/10 mg/20 mg

Minimum Order Quantity : 1530 Boxes

Drug Type : Specific Drug

Ingredients : Telmisartan 40 mg & 80 mg

Function : Other

Physical Form : Tablets

Recommended For : Hyperlipidemia and mixed Dyslipidemea, Primary Prevention of Cardiovascular Diseases



Back to top